Savara Pharmaceuticals
SVRA
#6595
Rank
โ‚ฌ0.52 B
Marketcap
3,07ย โ‚ฌ
Share price
-1.54%
Change (1 day)
-29.10%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -โ‚ฌ75.87 Million

According to Savara Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โ‚ฌ52.54 Million a decrease over its 2022 earnings that were of -โ‚ฌ36.65 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ75.87 Million44.39%
2023 -โ‚ฌ52.54 Million43.38%
2022 -โ‚ฌ36.65 Million-11.31%
2021 -โ‚ฌ41.32 Million-13.3%
2020 -โ‚ฌ47.66 Million-36.53%
2019 -โ‚ฌ75.09 Million13.76%
2018 -โ‚ฌ66.01 Million105.54%
2017 -โ‚ฌ32.12 Million34.11%
2016 -โ‚ฌ23.95 Million-37.43%
2015 -โ‚ฌ38.27 Million38.81%
2014 -โ‚ฌ27.57 Million33.62%
2013 -โ‚ฌ20.64 Million38.49%
2012 -โ‚ฌ14.9 Million24.59%
2011 -โ‚ฌ11.96 Million-36.5%
2010 -โ‚ฌ18.84 Million-3.14%
2009 -โ‚ฌ19.45 Million-23.28%
2008 -โ‚ฌ25.34 Million8.52%
2007 -โ‚ฌ23.36 Million-34.14%
2006 -โ‚ฌ35.46 Million184.43%
2005 -โ‚ฌ12.47 Million90.75%
2004 -โ‚ฌ6.54 Million190.35%
2003 -โ‚ฌ2.26 Million11.64%
2002 -โ‚ฌ2.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ17.44 Million-78.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.12 Billion 42.09%๐Ÿ‡บ๐Ÿ‡ธ USA